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Abstract
Background: Invasive aspergillosis is started after germination of Aspergillus fumigatus conidia that are inhaled
by susceptible individuals. Fungal hyphae can grow in the lung through the epithelial tissue and disseminate
hematogenously to invade into other organs. Low fungaemia indicates that fungal elements do not reside in
the bloodstream for long.
Results: We analyzed whether blood represents a hostile environment to which the physiology of A. fumigatus
has to adapt. An in vitro model of A. fumigatus infection was established by incubating mycelium in blood. Our
model allowed to discern the changes of the gene expression profile of A. fumigatus at various stages of the
infection. The majority of described virulence factors that are connected to pulmonary infections appeared not
to be activated during the blood phase. Three active processes were identified that presumably help the fungus
to survive the blood environment in an advanced phase of the infection: iron homeostasis, secondary metabolism, and
the formation of detoxifying enzymes.
Conclusions: We propose that A. fumigatus is hardly able to propagate in blood. After an early stage of sensing
the environment, virtually all uptake mechanisms and energy-consuming metabolic pathways are shut-down. The
fungus appears to adapt by trans-differentiation into a resting mycelial stage. This might reflect the harsh conditions in
blood where A. fumigatus cannot take up sufficient nutrients to establish self-defense mechanisms combined with
significant growth.
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Background
Aspergillus fumigatus is one of the most frequent causes
of fungal infections of immunocompromised patients,
with mortality rates of over 50 % [1–3]. The fungus can
invade susceptible patients through the lung and cause
invasive pulmonary aspergillosis (IPA) as the most
severe form. The survival of A. fumigatus in the host is
probably a multifactorial trait and not caused by a spe-
cific virulence strategy [4, 5]. Indeed, the fungus can
survive in competitive environments, a likely prerequisite
of its pathogenicity and worldwide ubiquitous distribution
in decaying organic material [6]. During IPA, fungal
hyphae penetrate the epithelial tissue of the lung, causing
angioinvasion, and eventually disseminate via the blood-
stream to colonize other organs [7, 8]. It is generally as-
sumed that the hyphae do not reside in the bloodstream
at significant amounts [9].
Several conditions and determinants that play a role
during pulmonary infection have been identified, in-
cluding hypoxia, thermotolerance, iron acquisition, and
secondary metabolite production [10–14]. The biosyn-
thesis of amino acids also appears important because
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is crucial for virulence [15] and several auxotrophic mu-
tants are avirulent [16, 17].
In order to better understand the infection process it
is crucial to establish suitable animal models that reflect
the infection in humans. An overview of infection
models to study the virulence of A. fumigatus is available
[18]. In most cases, the neutropenic or non-neutropenic
murine model of pulmonary aspergillosis is used [19]. In
these approaches, mice are treated for immunosuppres-
sion with chemotherapeutic agents and/or corticoste-
roids. The conidia as infectious propagules are either
applied intranasally or intratracheally, or they are ac-
tively inhaled by the animals in an aerosol chamber.
The mice develop respiratory distress and are sacrificed
when developing severe symptoms to reduce suffering
[20]. Importantly, this model mimics the dissemination
process upon invasive aspergillosis (IA) only to a limited
extent. Systemic IA is induced by injecting conidia into the
tail vein of mice or after intranasal and intratracheal ad-
ministration [21, 22], eventually resulting in colonization of
the kidney. In a model of cerebral aspergillosis, conidia are
injected intracerebrally into mice or rats [23, 24]. These
models have proven very valuable for testing novel drugs,
but since the lung is not affected in these models, the dissem-
ination process in human IA is mimicked only partially [25].
Transcriptomic and proteomic approaches are well suit-
able to identify a wide spectrum of factors involved in in-
fection. In theory, mouse models should allow to measure
the expression of fungal genes during infection. However,
it has remained a challenge to obtain sufficient fungal
material for the analysis of RNA. Therefore only three
approaches with material from infection models had been
published so far [26–28]. By microarray-based hybridiza-
tions, the transcriptome of A. fumigatus was determined
at an early stage of infection that is after germination of
the conidia in the lung. It was observed that the fungal
transcriptome displayed changes that imply iron limita-
tion, alkaline stress, and nutrient deprivation. To profile
under isolated conditions and overcome the limited avail-
ability of material, in vitro approaches were carried out
mimicking certain infectious environments. Transcrip-
tome data were obtained from various experimental
conditions like hypoxia, thermostress, oxidative stress,
interaction with cells of the immune system and vary-
ing growth conditions [29–35]. Several transcriptome
analyses dealt with recombinant strains deleted for
known virulence factors with regulatory properties like
MpkA, GprD/C and LaeA [36–38]. The latter showed
that in a ΔlaeA background many clusters are differen-
tially expressed that are likely to reflect changes affect-
ing the biosynthesis of secondary metabolites. Gene
expression profiles were also investigated during anti-
mycotic treatment. For example, amphotericin B in-
duced transcription profile changes affecting genes
related to the ergosterol pathway, cell stress, cell wall,
and transport [39], while voriconazole affected the
ergosterol and cAMP PKS signaling-pathways [40].
These transcriptome data were mostly obtained using
various microarray hybridization platforms and in some
cases cDNA sequencing at high throughput (RNA-Seq).
A comparison of several published transcriptome data-
sets has revealed that results from different RNA-Seq
datasets are more comparable among each other than
those arising from different microarray platforms [37].
Thus, RNA-Seq is currently the method of choice to
monitor gene expression in any microorganism, such as
A. fumigatus.
During aspergillosis, the shift from pulmonary colo-
nization to that of other organs is rather transient. The
dissemination process is difficult to mimic, despite it
is an important stage of the infection because the
colonization of organs relates to the high mortality
during aspergillosis. Drugs that target this stage could
be capable of blocking the dissemination and thus pre-
vent rapid life threatening progression of the infection.
Knowledge is scarce about the fungal gene expression
changes to adapt to the harsh conditions within the
bloodstream. The fungal burden in blood is generally
too low to be detected by blood cultures. The human
pathogenic fungus Candida albicans shows a similar
dissemination via the bloodstream during infection.
Upon incubation with blood C. albicans showed dif-
ferential expression in genes involved in general stress
response, antioxidative response, glyoxylate cycle and
hyphal growth [41].
We established an in vitro model for the incubation of
A. fumigatus in human blood in order to further deter-
mine how the fungus’ gene expression profile reacts to
this specific and relevant condition. We have used
RNA-Seq to determine the transcriptome of the fungus
incubated in blood or in minimal medium as reference
condition. Based on our results we propose that A.
fumigatus cannot significantly grow in blood. Instead,
after an early stage of sensing the environment, the fun-
gus adapts by entering a resting mycelial stage, thereby
shutting down virtually all uptake mechanisms and
energy-consuming metabolic pathways. This reaction
might reflect a condition in which A. fumigatus cannot
take up sufficient nutrients and protect itself against
the harsh conditions in blood at the same time.
Results and discussion
Investigating the transcriptome of Aspergillus fumigatus
incubated in human blood
Invasive aspergillosis is established after infection of
lung tissue by the dissemination of mycelial fragments
through the bloodstream. In order to determine transcrip-
tional changes during the inoculation of A. fumigatus
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mycelium in human blood, we set up an in vitro assay. For
this we used freshly drawn, heparinized blood from one
individual and harvested total RNA at different experi-
mental conditions. In a microarray pilot experiment we
monitored different time points. Based on these pilot ex-
periments we decided to select five conditions with two
biological replicates (r1 and r2) for further analysis in-
cluding the pre-culture (pre) prior to the change of
medium and a comparison between growth after half
an hour or three hours in either blood (B) or defined
minimal medium (M): pre, M30, B30, M180 and B180
(Fig. 1a). cDNA libraries were generated and subse-
quently sequenced on an IlluminaHiSeq 2000 platform
by GATC biotech (Konstanz, Germany). The statistical
method used for differential expression was NOISeq [42].
A control lacking heparin was omitted since previous ex-
periments in C. albicans did not show significant influ-
ence of heparin on fungal gene regulation [41].
Fig. 1 Schematic display of the in vitro blood model and mapping results. a For the in vitro model 2 ml mycelium from an overnight culture
were aliquoted and, except for the pre value, incubated in either blood or minimal medium (10 ml) for 30 and 180 min at 37 °C. The complete
mycelium was harvested immediately after the procedure and snap frozen in liquid nitrogen. RNA was isolated, cDNA libraries were generated
and Illumina high Seq 2000 sequencing was performed. b Total number of reads in each sample (Total reads), number of reads aligned to the
reference genome (Mapped reads), and number of mapped reads allocated to annotated genes (Reads to genes). These numbers are indicated
by the top side of the corresponding bars
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Analysis of differentially expressed genes
The transcriptome of the fungus was monitored in an
earlier stage (30 min) and at a later stage (180 min) in
the course of incubation in human blood or defined cul-
ture medium. The list of differentially expressed genes
(DEGs) exclusively expressed in blood (B30s and B180s)
was obtained by relating RNA levels from the blood con-
dition (B30, B180) and medium condition (M30, M180)
to the initial 16 h liquid culture (pre). The genes that
displayed similar differential expression in both were
subtracted. Hence, those genes that showed differential
expression only in blood are represented in the list (B30s
and B180s, s denotes stringent). Table 1 lists the top range
of differentially expressed genes (cutoff >2/<−2). A further,
less stringent list was obtained by additionally including
those genes that showed differential expression in both
medium and blood but to a lesser extent in medium when
compared to the blood condition (B30ls and B180ls). A
gene was included in the less stringent list when the
difference of the M value (log2-fold change) was more
than 0.8 in the conditions M30-pre to B30-pre (M180-
pre to B180-pre) (see Additional file 1: Table S2 sheet B
and C). Additional file 1: Table S2 sheet A lists the dif-
ferentially expressed genes (DEGs B30s, B180s and
B30ls, B180ls) used for further analysis. The number of
stringently differentially regulated genes in B30s was
777 (410 up and 367 down regulated) whereas in B180s
this number was reduced to 584 genes (266 up and 318
down regulated). Similarly, 839 less stringently con-
trolled genes of B30ls (446 up and 393 down regulated)
corresponded to 652 genes in the B180ls list (290 up
and 362 down regulated) (Fig. 2). This corresponds to
approximately 8 % for B30 and 6 % for B180 of the
expressed genes. From the up-regulated DEGs at B180s and
B180ls only 40 % of the genes were functionally annotated.
Regulation patterns of transcriptome sequencing were in
accordance to quantitative real time (qRT) PCR experiments
applied to selected genes in order to verify the expression
data obtained by the RNA-Seq approach (Additional
file 2: Table S1). Genes were chosen from different cat-
egories: up-regulated in blood, not-regulated, or down-
regulated in blood. The obtained relative expression levels
of the biological control r2 showed in most cases equivalent
regulation when compared to the RPKM values of transcrip-
tome sequencing data (Fig. 3). Genes especially discussed in
the following paragraphs were tested with qRT-PCR on both
biological replicates r1 and r2 and compared to the cor-
rected RPKM from RNA-Seq (Additional file 3: Figure S1
A,B and C). Overall the data obtained by qRT-PCR were
highly consistent with the transcriptome sequencing data.
Functional analysis
We have employed the functional catalogue (FunCat)
and the gene ontology (GO) for the functional
enrichment analysis. The goal of this analysis was to
identify functionally enriched terms in the lists of DEGs
previously described. We used the FungiFun platform
for the B30s, B180s, and the less stringent B30ls, and
B180ls lists [43]. The results are presented for the ana-
lyses of the stringent conditions, while data for the less
stringent conditions will be given only if they principally
differ from the stringent conditions. The data are listed
in Additional file 4: Table S3 and summarized in Fig. 4.
We used the FunCat categories as the overall structure
of the presentation and additionally included relevant
GO term categories. Interestingly, the FunCat and GO
analyses displayed only minimal differences between the
stringent and the less stringent conditions, and only in
few cases additional categories were found to be enriched
(Fig. 4). From relevant categories several associated DEGs
were further investigated using the Aspergillus Genome
Database and links within to get a better understanding
about the function of the gene in the category [44]. In the
following sections the most striking categories and corre-
sponding DEGs are described and summarized in Table 2.
In Fig. 4 it is apparent that the majority of enriched
categories are linked at 30 min to up-regulated and at
180 min to down-regulated genes. In order to get a
better overview about the regulation in blood we
describe in the following sections four regulation pat-
terns of the functional enriched categories: early regu-
lation with the majority of up-regulated genes (at
30 min), early up-regulation and subsequent late down-
regulation, solely late down-regulation (at 180 min) and
late up-regulation. Some of the identified DEGs were also
tested with qRT-PCR to verify their regulation (Fig. 3 and
Additional file 3: Figure S1AB and C).
Changed expression after 30 min in blood primarily
connected to up-regulated genes
The functional enrichment analysis revealed that after
30 min in blood (B30s condition) most significantly
enriched categories correspond to up-regulated genes
and fewer to down-regulated genes (Fig. 4 and Additional
file 4: Table S3). The categories metabolism, and cell res-
cue, defense and virulence are enriched in both up- and
down-regulated genes. The categories mostly enriched in
up-regulation are transcription, protein fate, protein syn-
thesis, and transport. The category enriched by down-
regulated genes is cell cycle and DNA processing.
Metabolism
The metabolism category includes primary metabolism
as amino acid metabolism, lipid, fatty acid and isopren-
oid metabolism, sulfur metabolism and also secondary
metabolism. Up-regulated genes are involved in the me-
tabolism of the amino acids arginine or histidine and to
connections between amino acid metabolism and
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Table 1 List of the furthest differentially expressed genes in blood after 30 min (B30s) and after 180 min (B180s)
Afua Annotation B30s B180s
AFUA_8G01260 hypothetical protein −2.66 −2.05
AFUA_4G08420 hypothetical protein −2.25
AFUA_5G02700 MFS multidrug transporter −2.17 −1.51
AFUA_6G13380 arrestin (or S-antigen), N-terminal domain −2.17 −1.12
AFUA_4G09190 S-adenosyl-methionine-sterol-C- −2.15
AFUA_2G11260 3-isopropylmalate dehydratase −2.05
AFUA_4G08710 short chain dehydrogenase −2.00
AFUA_7G00970 GPI anchored serine-threonine rich protein 2.14 2.37
AFUA_6G12920 C2H2 finger domain protein 2.14
AFUA_2G05560 exonuclease 2.19
AFUA_3G10690 calcium-translocating P-type 2.19
AFUA_3G15080 hypothetical protein 2.20
AFUA_1G13070 U3 small nucleolar ribonucleoprotein protein 2.21
AFUA_6G14260 U3 small nucleolar ribonucleoprotein protein 2.23
AFUA_3G06380 exosome-associated family protein 2.24
AFUA_4G14180 hypothetical protein 2.25
AFUA_2G02500 hypothetical protein 2.26 1.60
AFUA_5G04010 tRNA-splicing endonuclease subunit Sen2 2.32
AFUA_2G02970 hypothetical protein 2.34
AFUA_6G03750 amidophosphoribosyltransferase 2.38
AFUA_8G01850 phosphate-repressible phosphate permease 2.43
AFUA_8G05720 DUF567 domain protein 2.44
AFUA_4G14190 hypothetical protein 2.46
AFUA_7G06030 alpha-ketoglutarate-dependent taurine 2.49
AFUA_4G12940 hypothetical protein 2.78 1.42
AFUA_5G08680 mitochondrial GTPase (YlqF) 2.93
AFUA_4G14160 hypothetical protein 3.06 3.18
AFUA_7G00340 metallo-beta-lactamase domain protein 3.10
AFUA_8G07170 hypothetical protein 3.13
AFUA_2G17240 C2H2 finger domain protein 3.25 3.32
AFUA_2G08180 flotillin domain protein 3.55
AFUA_6G04690 hypothetical protein 3.67
AFUA_3G03050 RNAse III 3.68 3.88
AFUA_3G01196 hypothetical protein 3.78 2.54
AFUA_8G04380 hypothetical protein 4.55 3.38
AFUA_8G05910 pectate lyase 4.58 3.91
AFUA_4G14170 hypothetical protein 4.89 3.75
AFUA_5G14410 cysteine dioxygenase 5.96 7.05
AFUA_7G05660 translation elongation factor eEF-3 −2.36
AFUA_5G05590 aspartokinase −2.37
AFUA_1G10130 adenosylhomocysteinase −2.09
AFUA_5G11340 translation initiation factor eIF-2B alpha −2.01
AFUA_8G05960 integral membrane protein 2.13
AFUA_2G05720 hypothetical protein 2.14
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pyrimidines, purines and carbohydrates. As down-
regulation for the category metabolism amino-acid me-
tabolism especially, metabolism of the aspartate family
and the pyruvate family are significantly enriched. The
category lipid, fatty acid and isoprenoid metabolism
bears genes that are up- and down-regulated. Two of
the up-regulated genes from this category,
AFUA_8G04080 (badA) and AFUA_8G04090 (codA),
are involved in glycine betaine biosynthesis (Table 2).
Glycine betaine was proposed to be used as an alterna-
tive nutrition pathway for amino acid biosynthesis
upon nitrogen starvation in A. fumigatus [45]. Thus it
is more suitable to add these genes into the category ni-
trogen, sulfur and selenium metabolism. From the
down-regulated genes related to lipid, fatty acid and
isoprenoid metabolism many genes were found to be
involved in the ergosterol pathway, the main sterol of
the fungal plasma membrane. The early down-
regulation of ergosterol biosynthesis is remarkable since
it is a main target for antifungal drugs like amphoteri-
cin B that is currently used for aspergillosis [46]. The
category secondary metabolism is enriched in the con-
dition B30 for up- and down-regulated genes. Only
three from the 11 genes that are up-regulated can be
directly related to secondary metabolism production
and for two the secondary metabolite is known (Table 2
and Fig. 5, see below for further description). From the
secondary metabolite category two genes that are
down-regulated are linked to fumigaclavine C or fumar-
ylalanine production called rps1 and sidE, respectively
[47, 48]. Fumarylalanine was described as immunomod-
ulatory drug and indeed sidE is up-regulated in murine
lung infection [26, 48]. Rps1 was shown to have an in-
fluence on oxidative stress and virulence in the insect
infection model Galleria mellonella [49]. Therefore it is
likely that these secondary metabolite products are
needed for infection but dispensable for the survival in
blood.
Transcription
In the category transcription the putative and known
function of the corresponding genes that are up-
regulated is in RNA synthesis, processing, modifica-
tion and in ribosomal RNA synthesis, processing, and
modification. The FunCat subterm ‘transcriptional con-
trol’ contains 23 genes that are up-regulated in B30s. Most
genes of this category have a more general role in tran-
scription (Table 2). Only few genes are known that show
Table 1 List of the furthest differentially expressed genes in blood after 30 min (B30s) and after 180 min (B180s) (Continued)
AFUA_5G02300 peroxidase 2.16
AFUA_8G01630 pyridine nucleotide-disulphide oxidoreductase 2.38
AFUA_4G00750 hypothetical protein 2.46
AFUA_5G13830 alpha-galactosidase 2.50
AFUA_8G05950 hypothetical protein 2.91
AFUA_7G06330 hypothetical protein 3.03
Genes with highest levels of differential expression are shown with a cutoff at > 2 or <−2. The number represents the log2-ratio or fold change for positive
(up-regulated) and negative (down-regulated) genes
Fig. 2 Number of differential expressed genes in blood culture. List for B30s and B180s contain differential expressed genes (DEGs) in blood
under stringent conditions. Under these conditions DEGs have no or opposite differential expression in the corresponding minimal medium condition.
B30ls and B180ls include differentially expressed genes under less stringent conditions, that also show regulation in minimal medium but to a
lesser or higher extend than in blood. For details see text. Positive values are up-regulated DEGs and negative values corresponds to the
number of down-regulated DEGs. In B180 up-regulated DEGs for few genes the function was characterized or predicted
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Fig. 3 (See legend on next page.)
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an obvious regulatory role in specific pathways. This is
AFUA_5G06190 (SteA), whose orthologous gene in A.
nidulans encodes a transcription factor that is involved
in sexual development [50], AFUA_5G05610 encoding a
putative cell cycle control protein and AFUA_1G12940
[51] for a MAP kinase that regulates transcriptional stress
response and plays a role in nitrogen starvation [52]. A
number of transcription factor-encoding genes are down-
regulated. These transcription factors are primarily in-
volved in DNA processing, development or metabolism.
Cellular transport
A number of genes which are up-regulated at B30s are
involved in a variety of transport processes (Table 2).
Some genes encode predicted electron transport and
one gene is for a putative toxin transporter. Only two
genes for putative amino acid transporters show differ-
ential transcription. AFUA_7G04290 (GapA), a general
amino permease transporting most amino acids, and
AFUA_8G02200 (for proline permease) are up-regulated
at the less stringent condition B30ls.
Cell rescue, defense and virulence
The categories cell rescue, defense and virulence are
enriched in up- and down-regulated genes at B30s. The
subterm stress response is related to up-regulated
genes. These include genes predicted to be involved in
DNA repair and in chaperone and protein folding activity
(Table 2). To the latter category belong AFUA_2G02320
(Hsp70 chaperone BiP) AFUA_4G03650 (ribosome
associated DnaJ chaperone Zuotin), AFUA_8G03930
(HscA), AFUA_2G16290 (DnaJ domain protein Mas5)
and AFUA_4G12360 (prefoldin subunit 1). SteA and
SakA already mentioned in the category transcription
can also be related to stress response and additionally
AFUA_5G11230 (RasA), is a GTPase that is involved in
asexual development and cell wall integrity [53]. Also
predicted detoxification proteins like the thioredoxin
reductase AFUA_4G12990, two putative transporters
AFUA_4G00930 and AFUA_1G12620 and the pre-
dicted hydrolase AFUA_2G13080, are up-regulated in
the B30s data set. The down-regulated genes from this
category belong to the subcategory resistance protein
and are putative transporters like AFUA_8G02050
(putative polysaccharide transporter), AFUA_1G03200
(MFS transporter), AFUA_1G10370 (MFS multidrug
transporter), AFUA_1G10390 (ABC multidrug trans-
porter), AFUA_1G13800 (MFS multidrug transporter),
AFUA_6G02220 (MFS toxin efflux pump), AFUA_5G02700
(MFS multidrug transporter), and AFUA_7G01790 (MFS
transporter). Also genes putatively involved in protein
folding and heat shock are down-regulated (Table 2).
(See figure on previous page.)
Fig. 3 Relative mRNA level regulation is comparable in most cases with RNAseq data. Comparison of relative mRNA expression from biological
replicate r2 using quantitative RT-PCR (qRT-PCR) and RNAseq of various genes show that both methods yield similar results in most cases. Shown
are representative genes that were identified as up-regulated in blood, down-regulated in blood and not regulated. Note that all graphs have
different scaling and show relative expression levels for qRT-PCR and RPKM values for RNAseq data
Fig. 4 Functional enrichment analysis with FunCat. The functional categories of the first level that are significantly enriched upon differentially
expressed genes from B30s, B30ls, B180s and B180ls. Few categories were found that are up-regulated in B180s and B180ls. P-value cutoff
was 0.005
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Table 2 Functional categorization of selected genes
Number Name Known description, putative function or ortholog function
B30 up-regulation
Secondary metabolism
AFUA_3G00840 FAD-dependent oxygenase, required for asperfuranone biosynthesis in A. nidulans (afoF)
FAD-dependant oxygenase; secreted protein
AFUA_3G12910 hasC O-methyltransferase GliM-like, orthologous member of the “has” secondary metabolite biosynthetic
gene cluster of strain A1163. [67]
AFUA_3G12930 hasE dimethylallyl tryptophan synthase SirD-like, orthologous member of the “has” secondary metabolite
biosynthetic gene cluster of strain A1163. [67]
Transcriptional control
AFUA_5G06190 steA sexual development transcription factor, involved in sexual development
AFUA_5G05610 putative cell cycle control protein Cwf14/Bud31, ortholog(s) have role in cellular bud site selection
AFUA_1G12940 sakA MAP kinase SakA, nitrogen sensing, is induced upon carbon and nitrogen starvation [52]
Transport
AFUA_1G12620 aflT MFS toxin efflux pump
AFUA_7G04290 GapA, putative amino acid transporter
AFUA_8G02200 proline permease, putative amino acid transporter
Stress response
AFUA_5G06520 low-temperature viability protein ltv1, ortholog(s) have role in cellular response to oxidative stress,
response to osmotic stress
AFUA_5G11230 rasA RAS small monomeric GTPase RasA, involved in cell wall integrity
Chaperone and protein folding activity
AFUA_2G02320 Hsp70 chaperone (BiP)
AFUA_4G03650 ribosome associated DnaJ chaperone Zuotin,
AFUA_8G03930 hscA Hsp70 chaperone HscA, Yap1-dependent induction in response to hydrogen peroxide; hypoxia induced protein
AFUA_2G16290 DnaJ domain protein Mas5, ortholog(s) have endoplasmic reticulum localization
AFUA_4G12360 prefoldin subunit 1, has domain(s) with predicted unfolded protein binding activity, role in protein folding
and prefoldin complex localization
Detoxification
AFUA_4G12990 trr1 thioredoxin reductase Trr1/Trr2
AFUA_4G00930 CorA family metal ion transporter, Mg transport
AFUA_2G13080 Nudix/MutT family protein, ortholog(s) have hydrolase activity
AFUA_1G12620 aflT MFS toxin efflux pump
Lipid acid and isoprenoid metabolism
AFUA_8G04080 badA betaine aldehyde dehydrogenase, involved in glycin betain biosynthesis [45]
AFUA_8G04090 codA choline oxidase, involved in glycin betain biosynthesis [45]
B30 down-regulation
Secondary metabolism:
AFUA_1G10380 nrps1 nonribosomal peptide synthase Pes1, essential for fumigaclavine C biosynthesis [47]
AFUA_3G03350 sidE nonribosomal peptide synthase SidE, involved in production of fumarylalanine [48]
Transcription
AFUA_1G12332 jumonji family transcription factor, has domain(s) with predicted zinc ion binding activity
AFUA_1G13750 C2H2 transcription factor Rpn4, proteasomal regulator in S. cervisiae
AFUA_1G15230 C6 transcription factor, ortholog(s) have role in conidiophore development, conidium formation, hyphal growth
AFUA_1G16460 bZIP transcription factor (LziP), ortholog(s) have role in asexual sporulation, sexual sporulation resulting in
formation of a cellular spore
AFUA_2G11780 CreA, C2H2 transcription factor
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Table 2 Functional categorization of selected genes (Continued)
AFUA_2G13260 medA MedA, transcriptional regulator of adherence, host cell interactions and virulence; required for
wild-type levels of conidiation
AFUA_2G14110 sulfur metabolite repression control protein, ortholog(s) have protein binding, bridging, ubiquitin
binding activity
AFUA_2G14680 flbB Bzip developmental regulator; role in asexual development, gliotoxin production
AFUA_2G16230 C2H2 finger domain protein, has domain(s) with predicted DNA binding, zinc ion binding activity, role in
transcription
AFUA_2G17220 C2H2 transcription factor (AmdX), ortholog(s) have sequence-specific DNA binding activity, role in
regulation of transcription
AFUA_3G02000 farB like, C6 transcription factor Ctf1B-like, putatively involved in fatty acid degradation
AFUA_3G05760 C6 transcription factor (Fcr1)
AFUA_3G06250 RNA polymerase II mediator complex component, has domain(s) with predicted RNA polymerase II
transcription cofactor activity
AFUA_3G11250 ace2 C2H2 transcription factor (Swi5), with a role in conidiophore development, pigment production,
germination and virulence
AFUA_3G12940 hasF C6 transcription factor, orthologous member of the “has” secondary metabolite biosynthetic
gene cluster of strain A1163. [67]
AFUA_4G03960 farA C6 transcription factor Ctf1A, with a role in beta oxidation of long-chain fatty acids
AFUA_6G12160 C6 transcription factor
Cell wall
AFUA_6G06340 gfa1 glucosamine-fructose-6-phosphate transaminase, chitin production
AFUA_2G01170 gel1 1,3-beta-glucanosyltransferase, biosynthesis of fungal cell wall [91]
AFUA_2G05340 gel4 1,3-beta-glucanosyltransferase, GPI-anchored to the plasma membrane; cell wall maintanance
Resistance proteins
AFUA_1G03200 mfsC MFS transporter
AFUA_1G10370 MFS multidrug transporter
AFUA_1G10390 abcB ABC multidrug transporter
AFUA_1G13800 MFS multidrug transporter
AFUA_3G02610 MFS transporter, has domain(s) with predicted role in transmembrane transport and integral
to membrane localization
AFUA_5G00980 MFS multidrug transporter, putative transporter of small solutes
AFUA_5G02700 MFS multidrug transporter, putative transporter of small solutes
AFUA_7G01790 ssu1 MFS transporter, putative sulphite efflux pump
AFUA_2G14570 zinc/cadmium resistance protein, ortholog(s) have zinc ion transmembrane transporter activity,
role in cellular zinc ion homeostasis
AFUA_6G02220 MFS toxin efflux pump
AFUA_8G02050 putative transporter of polysaccharides
Heat shock, chaperone activity
AFUA_1G07440 hsp70 molecular chaperone Hsp70
AFUA_1G06020 DnaJ domain protein, has domain(s) with predicted heat shock protein binding, unfolded protein
binding activity and role in protein folding
AFUA_1G11180 hsp78 heat shock protein/chaperonin HSP78
AFUA_1G15270 heat shock protein Hsp98/Hsp104/ClpA, ortholog(s) have cytosol, nuclear envelope localization
AFUA_3G14540 hsp30 heat shock protein Hsp30/Hsp42, putative 30-kDa heat shock protein
AFUA_4G12850 clxA calnexin, ER membrane chaperone involved in folding of glycoproteins directed to the
secretory pathway
AFUA_5G07340 DnaJ domain protein Psi, ortholog(s) have cytosol, nucleus localization, involved in protein folding
and translational initiation
AFUA_6G06470 heat shock protein Hsp30-like, putative integral plasma membrane heat shock protein
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Table 2 Functional categorization of selected genes (Continued)
B30 up-regulation and 180 min down-regulation
Protein/ peptide degradation and modification
AFUA_5G06060 skpA sulfur metabolism regulator SkpA, part of SCF ubiquitin ligase complex
AFUA_1G04040 ubiA ubiquitin
AFUA_5G04000 protein involved in proteasomal and 4S ribosomal subunit biogenesis
Peptidases
AFUA_3G05450 glutamate carboxypeptidase
AFUA_6G04510 O-sialoglycoprotein endopeptidase, ortholog(s) have chromatin DNA binding activity and role in
positive regulation of transcription from RNA polymerase II promoter
AFUA_6G07330 methionine aminopeptidase, type I, orthologs have functions in protein processing
Glycosylation
AFUA_6G12360 class I alpha-mannosidase 1A, has domain(s) with predicted calcium ion binding,
mannosyl-oligosaccharide 1,2-alpha-mannosidase activity
AFUA_4G10070 class I alpha-mannosidase, has domain(s) with predicted calcium ion binding, mannosyl-oligosaccharide
1,2-alpha-mannosidase activity
AFUA_1G12630 mannosylphosphate transferase (Mnn4), putative phosphorylcholine metabolism
AFUA_4G10750 alpha-1,6-mannosyltransferase subunit, Glycan biosynthesis
AFUA_5G05740 gmtA Golgi GDP-mannose transporter, involved in biosynthesis of the cell wall polysaccharide galactomannan
Phosphorylation
AFUA_6G12820 mpkB MAP kinase MpkB, putative mitogen-activated protein kinase
AFUA_5G11730 RIO1 family protein kinase, ortholog(s) have nucleocytoplasmic transporter activity, protein kinase
activity, role in maturation of SSU-rRNA
AFUA_1G12940 sakA MAP kinase SakA, nitrogen sensing, is induced upon carbon and nitrogen starvation [52]
AFUA_1G09170 protein kinase activator (Mob2), ortholog(s) have kinase binding activity and role in conidiophore
development, hyphal growth, regulation of kinase activity
AFUA_1G16000 serine/threonine protein kinase, has domain(s) with predicted ATP binding, protein tyrosine kinase
activity and role in protein phosphorylation
AFUA_2G13680 calcium/calmodulin-dependent protein kinase, orthologs have a function in stress response
AFUA_2G05490 HEAT repeat protein, ortholog(s) have deoxyhypusine monooxygenase activity
AFUA_3G12490 protein arginine methyltransferase RmtB, ortholog(s) have histone-arginine N-methyltransferase activity
AFUA_4G13400 glycosyltransferase family 28, ortholog(s) have N-acetylglucosaminyldiphosphodolichol N-
acetylglucosaminyltransferase activity
AFUA_5G01740 deoxyhypusine synthase, putatively first step in hypusine biosynthesis
180 min down-regulation
ATP binding (GO:0005524)
AFUA_1G02570 aspartyl-tRNA synthetase, cytoplasmic, aspartyl-tRNA synthetase; calcium downregulated
AFUA_1G05620 phenylalanyl-tRNA synthetase, beta subunit, ortholog(s) have phenylalanine-tRNA ligase activity
AFUA_1G05800 mkk2 MAP kinase kinase (Mkk2), putative mitogen-activated protein kinase kinase (MAPKK); essential for
cell wall integrity signaling; calcium induced
AFUA_1G09010 methionyl-tRNA synthetase, ortholog(s) have cytosol localization
AFUA_1G10310 RNase L inhibitor of the ABC superfamily, ATPase, Rnase L inhibitor, orthologs involved in
ribosome protection
AFUA_1G10630 S-adenosylmethionine synthetase, putative S-adenosylmethionine synthetase; involved in
methylation processes, biosynthesis of biotin and polyamines
AFUA_2G02320 Hsp70 chaperone (BiP)
AFUA_2G02590 aspartyl-tRNA synthetase Dps1
AFUA_2G03580 phenylalanyl-tRNA synthetase beta chain, ortholog(s) have phenylalanine-tRNA ligase activity
AFUA_2G04620 bipA Hsp70 chaperone BiP/Kar2
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Table 2 Functional categorization of selected genes (Continued)
AFUA_2G05650 cytoplasmic asparaginyl-tRNA synthetase, ortholog(s) have asparagine-tRNA ligase activity,
role in asparaginyl-tRNA aminoacylation and cytosol localization
AFUA_2G06110 chromatin remodeling and histone, ortholog(s) have role in chromatin silencing at centromere
AFUA_2G08670 acetyl-CoA carboxylase, ortholog(s) have acetyl-CoA carboxylase activity, biotin carboxylase
activity and role in long-chain fatty acid biosynthetic
AFUA_2G09290 hsp60 antigenic mitochondrial protein HSP60, involved in heat shock response
AFUA_2G13140 ime2 meiosis induction protein kinase, a serine/threonine protein kinase involved in mycotoxin
production and sex. development
AFUA_2G14030 arginyl-tRNA synthetase, ortholog(s) have arginine-tRNA ligase activity, role in arginyl-tRNA
aminoacylation and cytosol, mitochondrion localization
AFUA_3G05430 DEAD-box RNA helicase Dhh1/Vad1, ortholog(s) have translation regulator activity, nucleic acid
binding activity
AFUA_3G08650 C1 tetrahydrofolate synthase
AFUA_3G10300 putative galactokinase with a role in galactose catabolism
AFUA_3G10530 protein serine/threonine kinase (Ran1), orthologs have negative regulation of transcription/
development-meiosis
AFUA_3G13030 t-complex protein 1, gamma subunit (Cct3), ortholog(s) have unfolded protein binding activity,
role in cellular response to drug, protein folding
AFUA_4G07660 ded1 ATP dependent RNA helicase (Dbp1), ATP-dependent RNA helicase, cell cycle affected in S. pombe
AFUA_4G08060 tetrahydrofolylpolyglutamate synthase (Met7), role in one-carbon metabolic process, regulation
of DNA methylation and cytosol, mitochondrion
AFUA_4G13700 threonyl-tRNA synthetase, putative tRNA charging
AFUA_5G05490 seryl-tRNA synthetase,
AFUA_5G05960 serine/threonine protein kinase, involved in salt tolerance in S. cerevisiae
AFUA_5G07020 ribosome biogenesis ABC transporter Arb1
AFUA_5G09610 cysteinyl-tRNA synthetase, putative tRNA charging
AFUA_5G10550 ATP synthase F1, beta subunit, orthologs are required for synthesis of ATP, but are non-essential
AFUA_6G04730 bifunctional purine biosynthetic protein Ade1, ortholog(s) have phosphoribosylamine-glycine
ligase activity, phosphoribosylformylglycinamidine cyclo-ligase activity
AFUA_6G05080 ABC transporter, ortholog in S. cerevisiae involved in RNA regulation and maturation
AFUA_6G06870 casein kinase I homolog, ortholog(s) have magnesium ion binding, protein serine/threonine
kinase activity
AFUA_6G07540 t-complex protein 1, epsilon subunit, ortholog(s) have chaperonin-containing T-complex localization
AFUA_6G07640 lysyl-tRNA synthetase,
AFUA_6G12630 leucyl-tRNA synthetase, putative tRNA charging
AFUA_6G12820 mpkB MAP kinase MpkB, orthologs are regulating carbon utilization
AFUA_7G05660 translation elongation factor eEF-3
Transcriptional control
AFUA_2G11780 C2H2 transcription factor (CreA) ortholog(s) have carbon catabolite repression
AFUA_2G13260 medA transcriptional regulator of adherence, host cell interactions and virulence; required for wild-type
levels of conidiation
AFUA_2G16230 C2H2 finger domain protein, putative transcription factor, orthologs have predicted regulation
of gluconeogenesis and adherence
AFUA_2G17220 C2H2 transcription factor (AmdX), A. nidulans ortholog involved in regulation of acetamide
catabolism; regulates amdS transcription
AFUA_3G08010 ace1 C2H2 transcription factor (Ace1), involved in cation homeostasis and in response to abiotic stress
in A. nidulans
AFUA_3G10300 putative galactokinase ortholog in S. cerevisiae involved in conversion of alpha-D-galactose to
galactose-1-phosphate, a key step in galactose catabolism
AFUA_3G10530 protein serine/threonine kinase (Ran1), orthologs have negative regulation of transcription/
development-meiosis
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Table 2 Functional categorization of selected genes (Continued)
AFUA_3G11250 ace2 C2H2 transcription factor (Swi5), role in conidiophore development, pigment production,
germination and virulence
AFUA_4G10220 homeobox transcription factor (RfeB), ortholog(s) have role in conidiophore development,
conidium formation, hyphal growth, regulation nucleotide biosynthesis
AFUA_4G11480 C2H2 finger domain protein, S. cerevisiae ortholog is Zinc-regulated transcription facto
AFUA_4G12470 cpcA bZIP transcriptional activator of the cross-pathway control system of amino acid biosynthesis
upon starvation
AFUA_5G06190 steA putative transcription factor involved in sexual development
AFUA_6G02110 MADS box transcription factor Mcm1, orthologs are involved in cell cycle
Energy
AFUA_6G12930 acoA aconitate hydratase, is essential for energy metabolism, TCA cycle and lysine biosynthesis [59]
Transmembrane transport GO:0055085
AFUA_1G05020 putative sulfate transporter
AFUA_2G03860 zrfB plasma membrane low affinity zinc ion, Low affinity plasma membrane zinc transporter;
induced by zinc depletion
AFUA_2G14570 zinc/cadmium resistance protein, ortholog(s) have zinc ion transmembrane transporter activity,
role in cellular zinc ion homeostasis
AFUA_3G12900 hasB MFS transporter, orthologous member of the “has” secondary metabolite biosynthetic gene
cluster of strain A1163. [67]
AFUA_4G14230 MFS transporter, putative transporter of small solutes
AFUA_4G14670 MFS quinate transporter, has domain(s) with predicted substrate-specific transmembrane transporter activity
AFUA_5G00980 MFS multidrug transporter, putative transporter of small solutes
AFUA_5G02700 MFS multidrug transporter, putative multidrug resistant protein
AFUA_7G01790 ssu1 MFS transporter, putative sulphite efflux pump
AFUA_7G05220 putative mitochondrial carrier protein
AFUA_7G05420 mitochondrial intermembrane space protein Mia40, putatively involved in intermembrane space import
180 min up-regulation
DNA repair
AFUA_2G02090 agt O6-alkylguanine DNA alkyltransferase; role in DNA repair
AFUA_3G11610 nhp6 nucleosome binding protein, non-histone chromosomal protein ortholog in S. cerevisiae play
role in elongation and DNA repair
Transcription factors
AFUA_2G15680 transcription initiation factor iia small chain, ortholog(s) have TBP-class protein binding, activity
involved in preinitiation complex assembly activity
AFUA_4G03960 farA C6 transcription factor Ctf1A, role in beta oxidation of long-chain fatty acids
AFUA_7G06320 C6 transcription factor, has domain(s) with predicted DNA binding, sequence-specific DNA
binding RNA polymerase II transcription factor activity
Protein binding, degradation, modification
AFUA_5G05790 ubiquitin ligase subunit HrtA, ring finger protein rbxA, putative E3 ubiquitin-protein ligase;
NeddH-associated protein
AFUA_6G09160 ubiquitin conjugating enzyme Ubc8, negatively regulates gluconeogenesis by mediating the
ubiquitination of fructose-1,6-bisphosphatase [70]
AFUA_6G14210 ubiquitin conjugating enzyme UbcB, ortholog(s) have ubiquitin-protein ligase activity
AFUA_1G07470 atg8 autophagic death protein atg8, ribo involved in autophagy, determines the size of the
autophagosome, induced upon starvation
Systemic interaction with the environment
AFUA_4G00660 sensor histidine kinase/response regulator, putative stress sensor
Nitrilases/ cyanid hydratases
AFUA_6G13450 nitrilase, ortholog(s) have cyanide hydratase activity, nitrilase activity and role in cyanide catabolic process
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HscA and thioredoxin reductase were also confirmed
by qRT-PCR analysis (Additional file 3: Figure S1C).
Cell cycle and DNA processing
Cell cycle and DNA processing is a category that is
only significantly enriched for down-regulated genes at
30 min. These are predicted genes mainly involved in
DNA processing, in DNA restriction or modification,
and in DNA recombination and DNA repair. Several
histones belong to the list of down-regulation in B30s
(Table 2). Also some transcription factors, kinases and
genes putatively involved in cytoskeleton formation like
AFUA_2G14990 (tubulin), AFUA_7G01400 (kinesin family
protein BimC), AFUA_3G06280 (Rho GTPase activator
Rgd1), AFUA_1G13750 (C2H2 transcription factor Rpn4),
AFUA_2G17220 (C2H2 transcription factor AmdX), and
AFUA_3G11250 (C2H2 transcription factor Swi5) are in
this list. Rpn4 down-regulation was also confirmed at qRT-
PCR (Additional file 3: Figure S1C).
Genes up-regulated after 30 min but down-regulated
after 180 min in blood
These categories of differentially expressed genes show
an opposing regulation pattern after short or longer
blood exposure. They are first up-regulated in B30s and
later down-regulated in B180s. Further investigations of
Table 2 Functional categorization of selected genes (Continued)
AFUA_2G17500 cyanide hydratase/nitrilase, ortholog(s) have cyanide hydratase activity, nitrilase activity and role
in cyanide catabolic process
Oxidation-reduction process GO:0055114
AFUA_2G10960 adh2 putative alcohol dehydrogenase Adh2p, in S. cerevisiae is responsible for catalyzing the initial
step in the utilization of ethanol as a carbon source
AFUA_2G11250 aryl-alcohol dehydrogenase Aad14, unknown function
AFUA_2G15930 alcohol dehydrogenase, ortholog in S. pombe role in detoxifying alcohols and related
compounds, protecting against environmental stresses
AFUA_4G12990 trr1 thioredoxin reductase Trr1/Trr2, orthologs play a role in detoxification
Iron homeostasis [12]
AFUA_3G03640 mirB MFS siderochrome iron transporter MirB,
AFUA_3G03440 mirD MFS siderophore iron transporter, expression upregulated under low iron condition
AFUA_7G06060 sit1 siderochrome-iron transporter Sit1,
AFUA_1G17270 fre2 FRE family ferric-chelate reductase, metalloreductase involved in response to iron starvation;
reductive iron assimilation, freB
AFUA_3G03410 sidH enoyl-CoA hydratase/isomerase family protein, mevalonyl-CoA hydratase; is essential for
(TAFC) biosynthesis
AFUA_3G03400 sidF siderophore biosynthesis acetylase AceI, hydroxyornithine transacylase; involved in extracellular
siderophore biosynthesis; essential for TAFC biosynthesis
AFUA_3G03420 sidD nonribosomal peptide synthase SidD, fusarinine C non-ribosomal peptide synthetase (NRPS)
involved in extracellular siderophore biosynthesisthesis
AFUA_3G03430 sitT ABC multidrug transporter SitT, involved in siderophore excretion
AFUA_3G03440 mirD MFS siderophore iron transporter,
AFUA_2G07680 sidA L-ornithine N5-oxygenase SidA, first committed step in siderophore biosynthesis; TAFC and
ferricrocin biosynthesis
Reductive iron assimilation
AFUA_5G03790 fetC ferrooxidoreductase Fet3,; reductive iron assimilation, FetC
AFUA_5G03800 ftrA high-affinity iron transporter FtrA, reductive iron assimilation, FtrA
Gluconeogenesis
AFUA_6G07720 acuF phosphoenolpyruvate carboxykinase AcuF, essential for gluconeogenesis
AFUA_4G11310 fbp1 fructose-1,6-bisphosphatase Fbp1, essential for glucenogenesis
AFUA_6G09160 ubiquitin conjugating enzyme Ubc8, n negatively regulates gluconeogenesis by mediating the
ubiquitination of fructose-1,6-bisphosphatase [70]
Adjusted categories and curated DEGs from FunCat and GO functional analysis that are refered to in the text. DEGs were manually investigated using the
Aspergillus Genome Database, http://www.aspergillusgenome.org/ (ASPGD). The known description, putative function or ortholog function obtained are directly
cited from ASPGD, from cited paper or description was obtained from link to S. cerevisiae genome project (http://www.yeastgenome.org/), from Candida Genome
Database (http://www.candidagenome.org/), from S. pombe pombase (http://www.pombase.org/) [92], and from Neurospora crassa Sequencing Project Broad
Institute of Harvard and MIT (http://www.broadinstitute.org/annotation/genome/neurospora/MultiHome.html)
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the DEGs included in these categories showed a subset
of them appearing in the 30 min and the 180 min list
simultaneously. However, most of the other DEGs that
appear in one list only show the same regulation pattern
but fall below the threshold of 30 min or 180 min.
So the majority of the DEGs described here have a
similar regulation pattern, although not all are repre-
sented in both conditions (Additional file 4: Table S3).
Protein synthesis and fate
A large number of DEGs belong to the category ‘pro-
tein synthesis’ and have the early up- and late down-
regulation pattern. They belong to the subcategories
ribosome biogenesis, translation, translational control
and translational initiation. Synthesis of ribosomes is a
very energy-consuming mechanism [54]. The early up-
regulation reflects the fungus is investing energy for
protein synthesis and hence metabolic changes whereas
the shut off of metabolic activity reflects down-regulation
and energy saving.
Protein fate with the subterms protein modification
and protein/ peptide degradation is enriched for up-
regulated genes in B30s. Genes that are predicted to be-
long to this category are AFUA_1G04040 (UbiA) and
AFUA_5G06060 (SkpA) which are part of SCF ubiqui-
tin ligase complex [55]. This complex is necessary to
connect ubiquitin to the substrate that is bound to the
F-box protein and therefore directs it to protein deg-
radation at the 26S proteasome [56]. With the ubiquitina-
tion system the fungus has a tool to change the stability,
localization or activity of a protein. The protein deg-
radation also involves the following other proteins:
AFUA_5G04000 (proteasome maturation and ribosomal
biogenesis), AFUA_4G10070 (class I α-mannosidase, in-
volved in ER protein degradation) and various peptidases
with unknown function. Also genes involved in glycosyla-
tion and phosphorylation are modifying proteins for
localization and activity and show the early up- and late
down-regulation pattern (Table 2).
Genes down-regulated after 180 min in blood
As described in the previous pattern at 180 min nearly all
significantly enriched categories correspond to down-
regulated genes. The categories metabolism, protein bio-
synthesis, protein fate, transport and energy are all related
to down-regulated genes.
Metabolism
A number of genes which are down-regulated at B180s
enlisted to subcategories that are involved in the biosyn-
thesis or degradation of amino acids. This includes not
only genes with direct involvement of amino acid bio-
synthesis and degradation but also genes that are pre-
dicted to be involved in purine metabolism, nitrogen
and carbon utilization, polyamines synthesis and second-
ary metabolites. Assimilation of ammonia, metabolism
of the glutamate group is a category belonging to down-
regulated genes. Most of the genes in this list are con-
nected to TCA cycle, and transamination. But also genes
are down-regulated that directly relate to glutamate
degradation as nitrogen source like the predicted gene
AFUA_2G06000 (NAD+ dependent glutamate dehydro-
genase) as well as for the glutamate degradation via the
GABA shunt pathway the predicted genes AFUA_6G13490
(glutamate decarboxylase) and AFUA_5G06680 (4-amino-
butyrate transaminase GatA). The categories metabolism
Fig. 5 Regulation of the hexadehydroastechrome (HAS) cluster during blood incubation using RNAseq and qRT-PCR data. Genes from the HAS
cluster of secondary metabolites showed different regulation pattern. All values are fold change (log2). The qRT-PCR data were obtained using ex-
periment r1 and r2 in the same way as described in Additional file 3: Figure S1B. The red rectangles show up-regulated genes in blood. Empty
cells in the RNAseq did not have any significant differential expression of the corresponding gene at this condition
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of the cysteine aromatic group has several genes for aro-
matic amino acid production that are down-regulated.
These are specifically the genes for aromatic amino acid
biosynthesis such as AFUA_5G13130 (chorismate mutase)
and especially tryptophan production, a highly energy
consuming pathway [57]: AFUA_1G13090 (multifunctional
anthranilate synthase), AFUA_4G11980 (anthranilate
phosphoribosyltransferase), AFUA_2G13250 (bifunc-
tional tryptophan synthase TrpB). In the category ‘C-
compound and carbohydrate metabolism’ several of
the down-regulated genes, are predicted to be involved
in sugar, glucoside, polyol and carboxylate anabolism.
Energy
The subcategory ‘tricarboxylic acid cycle (TCA), elec-
tron transport chain’ contains 43 down-regulated genes
(Additional file 4: Table S3). They are predicted to be
related to aerobic respiration, TCA cycle, electron transport
chain, and metabolism of energy reserves. Several genes in-
volved in electron transport chain that are down-regulated
are directly involved in the process as: AFUA_1G02070
(putative mitochondrial Cytochrome C1), AFUA_4G03120
(putative mitochondrial cytochrome b2), AFUA_1G03510
(putative mitochondrial ATP synthase), AFUA_3G10110
(putative electron transfer flavoprotein-ubiquinone), and
several NADH-ubiquinone dehydrogenase. AFUA_3G07
810 (predicted succinate dehydrogenase, sdh1) and AFUA_
5G10370 (predicted iron-sulfur protein subunit of succin-
ate, sdh2) are additionally to electron transport chain
involved in the TCA cycle. In contrast to S. cerevisiae
which can ferment, the TCA cycle is necessary for gain-
ing energy in A. fumigatus [58]. Several genes which
are involved in the TCA cycle are down-regulated:
AFUA_1G06810 (putative aconitate hydratase, mitochon-
drial), AFUA_3G08660 (putative isocitrate dehydrogenase
Idp1), AFUA_5G04230 (citrate synthase Cit1) and
AFUA_6G12930 (AcoA), an aconitate hydratase which
is essential for energy metabolism in A. fumigatus
(Table 2). Since AcoA is essential for growth and the
deletion mutant of the corresponding gene in not
viable, the down-regulation at 180 min suggests that A.
fumigatus is virtually not generating energy [59]. AcoA
is not only responsible for citrate to isocitrate conversion in
the TCA cycle but also for homocitrate to homoisocitrate
conversion during lysine biosynthesis. So it is consistent
that two genes for the α-aminoadipate pathway for lysine
biosynthesis are also down-regulated: AFUA_6G07390
(LysB) a putative homoisocitrate dehydrogenase and
AFUA_3G11710 a saccharopine dehydrogenase. This is
an interesting aspect in respect to secondary metabol-
ism production, since lysine is necessary for β-lactam
antibiotics production [60].
In the less stringent condition B180ls the category
glycolysis is significantly enriched for down-regulated
genes, so again energy production is down-regulated.
One example AFUA_2G09790 (glucose-6-phosphate
isomerase) was also confirmed in qRT-PCR (Additional
file 3: Figure S1C) The category metabolism for energy
reserves include the genes predicted for glycogen bio-
synthesis AFUA_5G02480 (glycogen synthase Gsy1),
AFUA_2G13850 (protein phosphatase regulatory subunit
Gac1), and trehalose biogenesis AFUA_2G04010 (alpha,al-
pha-trehalose-phosphate synthase). Also AFUA_3G11830
(phosphoglucomutase PgmA) is down-regulated at B180s
which is involved in glycolysis as well as glycogen and
trehalose biogenesis [61].
Mitotic cell cycle and cell cycle control
The category mitotic cell cycle and cell cycle control is
highly enriched with 36 down-regulated genes (Additional
file 4: Table S3). In this category are predicted kinases,
phosphatases, cytoskeletal proteins, and histone related
proteins already described in other paragraphs.
Transcription
Transcriptional control shows a number of down-regulated
genes (Table 2). In this category is AFUA_4G12470 (CpcA)
a transcription factor that is required for the cross-pathway
control, a mechanism that provides amino acid supply
during amino acid starvation by increasing the synthesis of
biosynthetic genes. CpcA is partially required for virulence
[15] and its transcription pattern could be confirmed by
qRT-PCR (Additional file 3: Figure S1C). Further genes
from this category are AFUA_2G13260 (MedA), a develop-
mental modifier that is also required for adherence and
furthermore plays a role in virulence [62], AFUA_5G06190
(SteA) a transcription factor predicted to be involved in de-
velopment and sexual reproduction [50], AFUA_2G17220
C2H2 transcription factor AmdX putatively required
for growth and nitrogen starvation, AFUA_3G10300 a
putative galactokinase involved in stress response, and
AFUA_2G11780 C2H2 transcription factor with hom-
ology to the carbon catabolite repressor CreA [63].
Transmembrane transporter
The GO category ‘transmembrane transporter’ is exhi-
biting a down-regulation pattern. The function of the
transporters is in most cases yet unknown, but they are
often predicted to be multidrug transporter. Any in-
volvement in up-take mechanisms related to metabolism
is with the current state of knowledge yet elusive.
ATP binding
This GO category has a large number of genes that are
involved in a variety of biological pathways. The fungus
seems to reduce ATP binding and consumption which is
consistent with the finding of the same pattern of down
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regulated genes for ribosomal and protein biosynthetic
pathways which are also highly energy consuming.
Disease, virulence and defense
The less stringent list of down-regulation for B180ls sig-
nificantly enriches the category ‘disease, virulence and
defense’. The genes belonging to this category are
transporters, but also AFUA_3G03350 (SidE), which is
already down-regulated at 30 min and is involved in
fumarylalanine production [48].
Up-regulated genes after 180 min in blood
Very few categories are enriched that correspond to up-
regulated genes in the B180s condition.
Transcription
In the category ‘transcription’, the 11 genes up-regulated
are involved in DNA repair, three genes encode pre-
dicted transcription factors of yet unknown functions.
Protein binding, degradation, modification
AFUA_5G05790 is up-regulated and encodes the RbxA
homolog for the RING protein which is the catalytic
subunit of E3 ubiquitin ligases for protein modification.
Modification by ubiquitin changes protein stability, func-
tion or localization. Further genes involved in ubiquitin
modifications which often increase protein instability are
AFUA_6G09160 (ubiquitin conjugating enzyme Ubc8)
and AFUA_6G14210 (ubiquitin conjugating enzyme
UbcB). Also AFUA_1G07470 (autophagic death protein
Atg8) is up-regulated in B180s. Autophagy is a possibil-
ity for the fungus to deal with nutrient starvation like
nitrogen and iron shortage by recycling its own proteins
and is an alternative to proteasomal degradation via the
ubiquitin system [64]. Atg8 is required for autophago-
some formation and the mRNA is up-regulated during
starvation conditions in S. cerevisiae [65, 66]. It is pos-
sible that protein stability, modification and function are
required to be active at 180 min or to be maintain an
alert status to readily react on environmental changes.
Detoxification and stress
The enriched category systemic interaction with the envir-
onment reveals that two predicted nitrilases or cyanid
hydratases and AFUA_4G00660, a sensor histidine kinase/
response regulator predicted to be involved in osmotic
stress, are up-regulated at B180s. The GO term oxidation-
reduction process reveals that some genes that are pre-
dicted to be involved in oxidative stress are up-regulated
at B180s like three alcohol hydrogenases AFUA_2G10960
(alcohol dehydrogenase Adh2), AFUA_2G11250 (aryl-
alcohol dehydrogenase Aad14), AFUA_2G15930 (alco-
hol dehydrogenase, zinc-containing) and the putative
thioredoxin reductase encoding gene AFUA_4G12990
(Aspf29, an allergen and putative thioredoxin TrxA).
Iron starvation
Under less stringent evaluation, siderophore-iron trans-
port is significantly enriched for up-regulated genes
during the late stage. More detailed investigation re-
vealed that several genes of iron homeostasis are up-
regulated at B180 in RNA-Seq data as well as in qRT-
PCR results (Additional file 3: Figure S1A) [12]:
AFUA_3G03640 (MFS siderochrome iron transporter
MirB), AFUA_3G03440 (MFS siderophore iron trans-
porter), AFUA_7G06060 (siderochrome-iron transporter
Sit1), AFUA_1G17270 (FRE family ferric-chelate reduc-
tase), AFUA_3G03410 (enoyl-CoA hydratase/isomerase
family protein SidH), AFUA_3G03400 (siderophore bio-
synthesis acetylase AceI), AFUA_3G03420 (nonribosomal
peptide synthase SidD), AFUA_3G03430 (ABC multidrug
transporter SitT), AFUA_3G03440 (MFS siderophore iron
transporter), and AFUA_2G07680 (L-ornithine N5-
oxygenase SidA) are up-regulated at B180ls. The trans-
porter for reductive iron assimilation AFUA_5G03790
(ferrooxidoreductase FetC) and AFUA_5G03800 (high-
affinity iron transporter FtrA) are down-regulated at
B30s (Additional file 3: Figure S1A). The number of
genes shows that iron starvation occurs in blood and
that the fungus is forced to specifically up-regulate genes
for siderophore biosynthesis. This is in consistency with
the known iron starvation conditions during infection in
pulmonary aspergillosis [67]. Also it was already described
that A. fumigatus obtains iron from transferrin in human
serum by secretion of siderophore [68]. Our study con-
firms on transcriptional level that the fungus produces
siderophores in blood. The supply of iron seems to be
more important than to down-regulate the siderophore
biogenesis in order to save energy. This is most probably
because it is needed for several important processes like
electron transport, amino acid metabolism, DNA biosyn-
thesis and must be stored to have a rapid supply when
growth is reinitiated [12].
Gluconeogenesis
Gluconeogenesis is needed when glucose is no longer
available in the medium to produce hexose sugars. Glu-
cose is present in blood in a lower level (<1.0 g/l) than
in minimal medium (10 g/l) [69]. The predicted genes
that are essential for the enriched category gluconeo-
genesis are down-regulated in the early stage at B30s:
AFUA_6G07720 (phosphoenolpyruvate carboxykinase
AcuF), AFUA_4G11310 (fructose-1,6-bisphosphatase
Fbp1) and the negative regulator AFUA_6G09160 (ubi-
quitin conjugating enzyme Ubc8) which is involved in
numerous cellular processes. This suggests that glucose
levels might be initially still sufficient for the fungus
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after the transfer to blood [70]. However, mRNAs levels
encoding these enzymes appear to increase again at
B180 min. For Fbp1 belonging to the B180s list of up-
regulated genes, whereas acuF regained pre-expression
levels and does therefore not appear in the B180s list.
Transcript levels of the negative regulator Ubc8 in con-
trast do not recover. This might be a secondary effect
of the experimental setup. In vitro glucose might be
exhausted at 180 min and the fungus prepares for alter-
native carbon source metabolism and therefore shows
an earlier up-regulation of gluconeogenesis genes than
the minimal medium control. In the bloodstream there
would be enough glucose available, due to continuous
supply. So it can be assumed that the activation of glu-
coneogenesis is not an active process occurring in the
host bloodstream.
The hexadehydroastechrome secondary metabolite
cluster is partially up-regulated in blood
Two of the three secondary metabolite genes up-
regulated in B30s belong to a cluster that is able to
synthesize hexadehydroastechrome (HAS cluster) which
might be involved in fungal virulence [67]. We analyzed
the expression levels in our experimental setup for the
eight genes belonging to this cluster and found that
six genes of this cluster are significantly differentially
expressed (Fig. 5). Three genes are down-regulated
(hasA and hasF at B30s and hasB at B30s and B180s),
two are up-regulated at B30s exclusively (hasC and
hasE), and one is up-regulated at B180s (hasH). Fur-
ther analysis of the RPKM-corrected expression levels
revealed that hasD and hasE show higher expression
levels in B30s or B180s, respectively, but fall below the
threshold. qRT-PCR data showed similar up-regulation
and down-regulation pattern of the genes and the results
are summarized in Additional file 3: Figure S1B and Fig. 5.
The HAS-cluster is a secondary metabolite cluster that
is silent under laboratory culture conditions [71, 72].
Overexpression of hasA, a putative transcription factor,
leads to expression of all members of the cluster and
consequently to synthesis of HAS. Additionally, hasA
overexpression leads to increased virulence of A. fumiga-
tus in the mouse model albeit HAS, the end-product of
this cluster, could not be detected [67]. HAS synthesis is
based on L-tryptophan and L-alanine, so therefore is a
highly energy consuming pathway (see also tryptophan
biosynthesis at 180 min). It contains Fe(III) and in vitro
iron depletion abolished the production of HAS. Terezine
D,7 an intermediate of the HAS production with unknown
function, was detected in murine infections [67]. The
regulation data from this study reveal that most likely the
whole cluster is not up-regulated in blood but instead the
regulatory proteins like transcription factors and trans-
porters (HasA, HasB, and HasF) are down-regulated.
Hence, the up-regulation of hasC, hasE, and hasH is exe-
cuted by an unknown transcription factor and independ-
ent of hasA regulation. They lead to a different product
than HAS, which could be Tresine D,7 or an unidentified
product. These results are in line with the results from
[67] and are also supported by the transcriptome analysis
from the mouse model that showed exactly the same
regulation pattern for the cluster as our in vitro blood
results [26].
Summarizing the fungal gene expression response after
30 min in blood
Our data show that after 30 min in blood the fungus
specifically controls cellular transport, protein synthesis,
and metabolism. Metabolism reflects the response to the
environment how the fungus is obtaining nitrogen, car-
bon, and other nutritional needs. The up-regulation of
genes belonging to amino acid metabolism and nucleo-
side, nucleotide or nucleobase metabolism can be related
to nitrogen metabolism and as well to transcription in
general. No obvious changes in genes for pathways for
energy metabolism can be detected. Only the genes in-
volved in glycine betaine biosynthesis might be related
to starvation conditions [45], but the known factors for
other starvation conditions are not up-regulated. Hence
the genes related to the target of rapamycin (tor) pathway,
GABA shunt, areA and the genes from transcriptomic
analysis of nitrogen starvation are not up-regulated
[26, 73, 74]. Also key genes for gluconeogenesis (acuF),
amino acid starvation (cpcA) hypoxia response (srbA)
and iron starvation are not increased at the early blood
incubation condition [12, 14, 15, 75].
It is thought that A. fumigatus feeds mainly on amino
acids during infection. This is based on the observation
that uptake of isoleucine, valine and methionine for the
methylcitrate cycle is a prerequisite for infection [76].
Interestingly two amino acid transporters are up-
regulated at the early phase in blood with one being a
general permease and no transporter is up-regulated
in the late phase. It is possible that the amino acid up-
take at the 30 min time point occurs unspecific. The
fungus negotiates the supply of amino acids and de-
cides what is needed. A specific uptake is then no
longer needed at the later stage. Some amino acid bio-
synthesis genes are up-regulated in the early phase,
however more likely related to purine and pyrimidine
biosynthesis, which again might account for the adap-
tion process and need of protein production. The
elevated category transport reflects that the fungus
does take up compounds for metabolism and energy
production. As mentioned above glucose is present in
blood. Glucose has a function as catabolite repressor
[77], so it can be expected that the fungus does not
change the energy metabolism compared to minimal
Irmer et al. BMC Genomics  (2015) 16:640 Page 18 of 25
medium in the early phase of blood incubation and in-
deed in the category energy no directly related genes
were up-regulated at this early time point. Categories
involved in growth like cell cycle, DNA synthesis, ergos-
terol biosynthesis and cell wall synthesis are connected to
mostly down-regulated genes. When summarizing all cat-
egories enriched it becomes obvious that the fungus is not
in a growth but in an adaption phase at 30 min, shutting
down and inducing different metabolic pathways in order
to synthesize new proteins to deal with the new condition.
Hence also genes for secondary metabolism and cell
rescue defense and virulence show both, up-and down-
regulation. So the stress response and defense strategies
are adapting during this condition.
Summarizing the fungal gene expression response after
180 min in blood
Most of the categories enriched in the late stage show
down-regulation. This reflects that the fungus is mas-
sively slowing down metabolism, saving energy, and is
in a no growth phase. This is a specific activity and not
due to an exhaust of nutrition, shown by the down-
regulation of known transcription factors that should
be induced under starvation conditions like cpcA, areA,
and also genes for amino acid degradation and biosyn-
thesis. Categories for transport, transcription factors
and ATP-binding are down-regulated presumably to
save energy. Genes like the essential aconitase hydra-
tase acoA [59] or ribosome synthesis reflects that en-
ergy saving is the main focus at this condition. Also
genes for tryptophan biosynthesis, a very cost intensive
amino acid production are down-regulated. The shut-
down of most of the energy consuming pathways might
be interpreted as a defense strategy to hide until environ-
mental changes enable the fungus to grow. This might
explain why the fungus is not found at high levels in blood
during invasive aspergillosis but instead it can only ac-
tively grow by colonizing tissue to get all the nutrients
necessary for active growth. The assumption that the fun-
gus is literally resting in the late phase, corresponds to our
observation that after 24 h in blood the mycelium did not
show any growth but transition to new medium reinitiated
growth again (data not shown). Our attempts to quantify
metabolic activity of the fungus under this experimental
condition failed due to a significant auto-fluorescence
of blood.
The exception of the energy saving mode is the up-
regulation of mechanisms putatively needed for active
protection and survival in blood. Hence expression is
more important for survival than energy conservation
aspects. The mechanisms are some genes from protein
degradation and autophagy, genes from detoxification
processes by nitrilases but also for coping with starva-
tion conditions for iron. Gluconeogenesis is most
probably not an active process for blood survival but an
artifact due to the experimental setup as described earlier.
Functional evidence about the high number of DEGs
coding for hypothetical proteins in the condition B180s
would probably reveal more survival strategies of the fun-
gus in the blood environment that are still unknown.
The iron homeostasis, corresponds to the known iron
starvation conditions during infection in pulmonary as-
pergillosis [67]. The second active protection mechan-
ism is related to detoxification, like thioredoxin, alcohol
dehydogenase and cyanid hydratase [78–80]. All these
proteins have orthologs that play a role in stress re-
sponse but they have not been studied in detail in A.
fumigatus. Also the partial up-regulation of the second-
ary metabolite cluster HAS, which starts already at
30 min, but the last member is up-regulated at 180 min
might play a role in actively ensuring survival in blood.
This cluster is especially interesting because it is not
expressed under different laboratory conditions and the
same partial regulation of the genes in this cluster was
also observed in the mouse model transcriptome [26].
In a phase in which most of the energy consuming
pathways are down-regulated it is not likely that the
up-regulation of the HAS genes utilizing, tryptophan is
unspecific. To verify that no other known secondary
metabolite cluster was up-regulated we compared our
data with the identified clusters that are affected by the
methyltransferase LaeA. The transcriptome data, did
not show much correlation to our results and also no
LaeA independent cluster was up-regulated [38]. So we
conclude that these secondary metabolite clusters are
not needed to survive in or adapt to blood, hence these
clusters might be needed at a later stage of infection.
However, it is possible that unidentified genes partici-
pate on the production of unknown secondary metabo-
lites that are needed for protection of the fungus in
blood. The high number of up-regulated unknown
genes might contribute for this.
Comparison to other transcriptome assays
We also compared transcriptome analysis from other
setups in Aspergillus fumigatus. The percentage of differ-
entially expressed genes in these analysis ranges between
2 % of the total genes for dendritic cell exposure to 23 %
for voriconazol exposure [33, 40]. The 6–8 % of DEGs
from our study is located in the lower range compared
to the other analysis. Again, little correlation is seen
between known virulence factors and our blood incuba-
tion results. Besides the partial HAS cluster a second
cluster showed a similar regulation pattern in the mouse
model transcriptome [26]. The second half of cluster 33
showed similar up-regulation of 5 out of the 14 genes.
The genes regulated are involved in siderophore metab-
olism and TAFC biosynthesis. A consistency with iron
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starvation conditions was already mentioned above.
Other comparisons using transcriptome data obtained
by incubation with dendritic cells, neutrophils, upon
nitrogen starvation, alkaline stress, oxidative stress did
not show any strong similarities [26, 30, 33, 35]. We
conclude that the dissemination process during asper-
gillosis leads to a very different reaction compared to
the other stages of infection. The fungus seems not to
proliferate and to take up any nutrients at all after a
short adaption phase. Since massive proliferation is
seen in the later dissemination state when the fungus col-
onizes other organs, it must be able to obtain enough
nutrition for growth from the organs [8]. This is probably
due to necrotic abilities on tissue, by secreting hydrolytic
enzymes that are rapidly released upon contact with the
tissue [81–83].
For Candida albicans it is described that during in vitro
blood incubation it can be observed that the fungus is
ready to leave the harsh environment of blood [41]. This
can be seen by the transition from yeast form to hyphae.
Hyphal specific genes, hydrolases and adhesion factors are
up-regulated in late phases of blood incubation so that the
fungus gains the ability to penetrate the tissue. A similar
preparation of A. fumigatus to leave the blood is not seen
in the transcriptome during blood incubation. But since
no morphological different infectious state is described
for A. fumigatus this seems to be impossible to detect.
Making iron available through siderophore production
might reflect that the fungus is preparing for an escape
from blood and hence a re-initiation of growth. Differ-
ences to the C. albicans transcriptome in blood are also
seen with other mechanisms. Iron deficiency for ex-
ample is not a problem, since C. albicans can utilize
haem from blood [84]. In the transcriptome the up-
regulation of the glyoxylate cycle is not seen in A. fumi-
gatus. Also less genes involved in antioxidative response
are regulated. Hence for example neither SOD, nor
catalase are up-regulated. One from the five catalase genes
is even down-regulated at 30 min in A. fumigatus. A simi-
lar behaviour of C. albicans to A. fumigatus is seen when
the yeast is incubated with neutrophils, where it under-
went growth arrest and nutrient starvation [85].
Conclusions
Invasive aspergillosis, an infection caused in most cases
by Aspergillus fumigatus, starts in immunocompromised
patients in the lung by inhalation. From there fungal
hyphae can grow through the epithelial tissue and dis-
seminate via the bloodstream to colonize other organs.
Presumably the fungus only stays in short time periods
in the blood since outgrowth from blood is difficult to
achieve and is less efficient than in Candida. Little is
known about the dissemination phase during invasive
aspergillosis. It was suggested that hyphal fragments de-
tach and spread to infect other organs [86]. From our
transcriptome data we assume that the situation may be
more complex. The fungus appears to sense the new en-
vironment and adapts within hours to it by shutting
down all unnecessary pathways in order to hide as long
as possible in the blood and to escape as soon as pos-
sible just keeping live saving mechanisms running.
Moreover, the possibility of hematogenous dissemination
by a Trojan horse mechanism, i.e. assisted by phagocytes
of the host immune system, has to be taken into account
[87], and it might well be possible that both dissemin-
ation processes occur simultaneously.
Transcriptome analysis can only supply limited infor-
mation on gene expression levels. So further studies on
the level of protein amounts are necessary to better
understand the cellular status of A. fumigatus in blood.
Also functional characterization of some of the large
number of genes that are currently annotated with un-
known function might shed light on the dissemination
process during invasive aspergillosis.
Methods
Strain, media, and preculture
The Aspergillus fumigatus ATCC46645 strain was used
in this study [88]. The minimal medium used consists of
1 % glucose, 2 % salt Solution (26 g/l KCl, 26 g/l MgSO4,
76 g/l KH2PO4, 5 % (v/v) trace elements) pH 7.0 plus
5 mM NH4-tartrate. The blood was withdrawn from one
female donor using heparinized syringes and was pooled
and immediately used. Mycelium of the A. fumigatus
strain was grown 16 h in minimal medium, harvested,
and pooled before transfer to the experimental culture
conditions.
In vitro blood assay
For each biological control the mycelium was split in ap-
proximately 2 ml into reaction tubes. One tube without
new medium was harvested and the mycelium was
shock frozen in liquid nitrogen yielding the pre value.
Concurrently 10 ml of either medium or blood was
added to the rest of the tubes, they were several times
inverted and incubated on a rotator at 37 °C for 15, 30,
60, 90, 180 min followed by harvesting and shock freez-
ing in liquid nitrogen.
Ethics statement
The local ethics committee (Ethikkommission der Uni-
versitätsmedizin Göttingen, Von-Siebold-Str. 3, D-37075
Göttingen, Germany under the chair of Prof. Jürgen
Brockmöller) expressed no ethical or legal concerns about
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the procedures as used in the present investigation and
approved the procedures using human blood samples.
RNA isolation and microarray
A. fumigatus mycelia was disrupted by grinding with li-
quid nitrogen, and total RNA was extracted with RNeasy
plant (Qiagen, Germany) following the instructions by
the manufacturer.
RT PCR and quantitative PCR
DNase digestion and subsequent cDNA synthesis was
carried out in duplicates for each sample using 0.8 μg of
RNA with the QuantiTect Reverse Transcription Kit
(Qiagen). Amplification was performed in a Light Cy-
cler 2.0 (Roche) with the RealMasterMix SYBR ROX
(5Prime) using 1 μl of a 1/10 dilution of cDNA and A.
fumigatus primers (Additional file 5: Table S4). Amplifi-
cation conditions were as follows: 50 cycles of 95 °C
18 s, 63 °C 45 s and an adjacent melting step (63–95 °C).
The amount of gene of interest relative to akuA and h2A
mRNA was quantified using the delta delta CT method
with efficiency [89]. All qRT-PCR experiments were per-
formed at least in duplicates [56].
cDNA library construction and sequencing
For sequencing, a new RNA preparation was carried out
using the same deep frozen and ground mycelium and
the same method as for quantitative RNA. The prepar-
ation of cDNA libraries were carried out by GATC Bio-
tech with two different methods. For the first replicate
(r1) the time point pre, B30 and B180 the SMART
protocol was used and for r1 M30 and M180 and all r2
time points the TrueSeq protocol was used. For the
SMART protocol, reverse transcription was carried out
with Oligo d(T) primers followed by second strand syn-
thesis, coligation, nebulization and adapter ligation. The
three tagged cDNA libraries were pooled and paired end
sequencing (Read length 100 bp) was performed on
Illumina HiSeq 2000 by GATC Biotech (Konstanz,
Germany). For TrueSeq, PolyA RNA was isolated, frag-
mented and random primed first strand cDNAs synthe-
sis was carried out. Afterwards second strand synthesis
was performed, adapters were ligated and the 7 tagged-
libraries were pooled for sequencing. Paired end sequen-
cing (Read length 100 bp) was carried out on Illumina
HiSeq 2000 by GATC Biotech (Konstanz, Germany).
Mapping, batch correction and expression quantification
The sequencing reads were mapped to the A. fumigatus
reference genome (strain Af293, version 14) which was
downloaded from EnsemblFungi website [40] using the
TopHat software [41]. In order to obtain the number of
reads mapping to annotated genes (expression quantifi-
cation), htseq-count tool was used (Anders S.: HTSeq:
Analysing high-throughput sequencing data with Py-
thon. http://www-huber.embl.de/users/anders/HTSeq/
doc/overview.html). Figure 1b show the total number
of reads, the number and percentage of reads mapping
to the reference genome (uniquely or to more than one
position) and the number of reads allocated to anno-
tated genes.
The samples were not sequenced at the same time but
in two different batches. A first exploratory Principal
Component Analysis (PCA) revealed an important batch
effect given that the first principal component separated
the two batches and explained 81 % of the total variabil-
ity (Fig. 6a). This batch effect caused that the correlation
between replicates within the same experimental con-
dition was sometimes lower than the correlation be-
tween conditions. We used ASCA method [90] on
log2(RPKM + 1) in order to remove this batch effect
from the data. ASCA first decomposes the data matrix
into several submatrices, one per effect to be studied
plus the residual one, which collects the part of the
data than cannot be explained by any of the effects in-
cluded in the analysis. Then, ASCA applies a PCA to
each one of the submatrices. We included only the
“batch” effect in the ASCA model and we subtracted
from the data the part being explained by the batch ef-
fect. By doing this, those genes contributing most to
the batch effect, are more corrected. Since not all the
genes and samples are corrected in the same way, the
resulting data have as a drawback that the expression
for a given gene is not comparable among samples. We
rescaled the data by applying quantile normalization to
solve this problem and added a constant value to these
quantile-normalized data to avoid negative expression
values.
Figure 6b shows the PCA plot for the corrected data
where no batch effect is observed. In this PCA, both
conditions and replicates are properly clustered (with a
correlation between replicates that varies from 0,95 to
0,97 and that is higher than the correlation between ex-
perimental conditions). Now, the first component ex-
plains 53 % of the variability in the data and it separates
incubation time: the later time points in the left-hand
side and earlier time points in the right-hand side. The
second component separates blood from minimal
medium samples.
The NOISeq method [42] was applied on the batch-
corrected data to compute differential expression. Genes
were declared as differentially expressed when the prob-
ability of differential expression was higher than 0.8.
Additional file 2: Table S1 shows the differentially
expressed genes (DEGs) for each comparison.
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Functional enrichment
Up-regulated or down-regulated genes from B30s, B30ls,
B180s and B180ls as listed in Additional file 1: Table S2 were
uploadedontheFungiFunplatformwithap-valuecutoffof0.05
andanalyzedforGOandFunCatfunctionalenrichment[43].
Availability of supporting data
The data discussed in this publication have been submit-





Fig. 6 Principal component analysis (PCA). a: PCA on log2(RPKM + 1) values. b: PCA computed from data after ASCA correction of batch effect
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Additional files
Additional file 1: Table S2. Sheet A: List of differential expressed genes
in blood after 30 min and after 180 min in stringent (B30s/B180s) and
less stringent (B30ls/B180ls) conditions. Sheet B and C: Genes included
and excluded from the B30 (B) and B180 (C) lists were obtained by
following method. Stringent (s) stands for no or opposite differential
expression in the corresponding minimal medium condition. The list of
genes with differential expression under less stringent conditions (ls) was
obtained by adding those genes to the stringent condition lists that
were differentially expressed to lower or higher extend than the blood
values. A gene was included when the difference of the M value was more
than 0.8 for positive values or less than −0.8 for negative values in the
comparison M30/M180-pre to B30/B180-pre. M represents the log2-ratio or
fold change for positive (up-regulated) and negative (down-regulated)
genes. D is the absolute value of the difference. Prob. is the probability of
differential expression obtained by NOISeq method. (XLS 1261 kb)
Additional file 2: Table S1. List of differential expressed genes at
different comparisons. Positive values show up-regulation within the first
condition compared to the second condition. Down-regulation accordingly
is represented by negative values. The value represents the log2-ratio or fold
change (M). (XLS 326 kb)
Additional file 3: Figure S1. Comparison of relative mRNA expression
from biological replicate r1 and r2 using quantitative RT-PCR (qRT-PCR)
and RNA-Seq of various genes show that both methods yield similar results
in most cases. Note that all graphs have different scaling and show
relative expression levels for qRT-PCR and RPKM values for RNA-Seq
data. A. Comparison of quantitative RT-PCR and RNAseq data of DEGs
involved in iron metabolism. The two biological replicates are shown in
RPKM values (RNAseq) and relative expression levels (qRT-PCR). The
middle column shows the obtained corrected RPKM values from both
replicates. B. Comparison of quantitative RT-PCR and RNAseq data of
DEGs from the Hexadehydroastechrome (HAS) cluster. Columns as
mentioned in A. C. Comparison of quantitative RT-PCR and RNAseq data
of some DEGs discussed on different paragraphs in the text. Columns as
mentioned in A. All mRNA levels were measured by qRT-PCR with primers
specific for the corresponding gene (Additional file 5: Table S4), and
normalization with akuA primers were carried out. The delta CT method
including efficiencies was used for quantification. (ZIP 940 kb)
Additional file 4: Table S3. List of differential expressed genes (DEGs)
related to the significantly enriched categories from the FunCat and GO
functional analysis. A p-value of 0.05 was used for the enrichment method.
For FunCat the first and second level is shown and when appropriate even
higher levels. (XLS 28782 kb)
Additional file 5: Table S4. Oligonucleotides used for quantitative RT-PCR.
(XLS 43 kb)
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